Targeted intervention through a multifactorial approach

The Swiss Society of Nephrology (SGN) advocates targeted screening for defined risk groups. However, given the prevalence of chronic kidney disease (CKD) in primary care, it is hardly possible to refer everyone affected to a nephrologist. Clear risk stratification is therefore essential. Drug therapy is based on several pillars and aims to slow down the rate of progression of GFR decline on the one hand and to reduce the cardiovascular risk on the other.